Literature DB >> 15043098

Risk factors affecting outcome of metal-on-metal surface arthroplasty of the hip.

Paul E Beaulé1, Frederick J Dorey, Michel J Le Duff, Michel LeDuff, Thomas Gruen, Harlan C Amstutz.   

Abstract

We evaluated radiologic and clinical features affecting the outcome of hybrid metal-on-metal surface arthroplasty of the hip in 119 hips in patients 40 years and younger. Only the hips that had either failed or had minimum 2-year followup were reviewed. Ninety-four hips in 83 patients with a mean age of 34.2 years (range, 15-40 years) were reviewed. Seventy-one percent of the patients were males and 29% of the patients were females; 14% had previous surgery. The Chandler index and surface arthroplasty risk index were calculated. The mean followup at 3 years (range, 2-5 years) showed that three hips were converted to a total hip replacement at a mean of 27 months (range, 2-50 months) after the original surgery, and 10 hips had significant radiologic changes. The mean surface arthroplasty risk index for these 13 problematic hips versus the remaining hips was significantly higher, 4.7 and 2.6, respectively. The mean angle between the prosthesis stem and femoral shaft in the problematic group was significantly smaller than in the remaining hips: 133 degrees and 139 degrees, respectively. With a surface arthroplasty risk index score greater than 3 the relative risk of early problems is 12 times greater than if surface arthroplasty risk index less than or equal to 3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043098

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  51 in total

1.  High revision rate at 5 years after hip resurfacing with the Durom implant.

Authors:  Florian D Naal; Ronny Pilz; Urs Munzinger; Otmar Hersche; Michael Leunig
Journal:  Clin Orthop Relat Res       Date:  2011-01-29       Impact factor: 4.176

2.  Indications and results of hip resurfacing.

Authors:  D J W McMinn; J Daniel; H Ziaee; C Pradhan
Journal:  Int Orthop       Date:  2010-11-16       Impact factor: 3.075

3.  2011 Marshall Urist Young Investigator Award: when to release patients to high-impact activities after hip resurfacing.

Authors:  Katherine M Bedigrew; Erin L Ruh; Qin Zhang; John C Clohisy; Robert L Barrack; Ryan M Nunley
Journal:  Clin Orthop Relat Res       Date:  2011-10-18       Impact factor: 4.176

Review 4.  [Resurfacing arthroplasty of the hip].

Authors:  A Knecht; W-C Witzleb; K-P Günther
Journal:  Orthopade       Date:  2005-01       Impact factor: 1.087

5.  2008 Otto Aufranc Award: component design and technique affect cement penetration in hip resurfacing.

Authors:  Paul E Beaulé; Wadih Y Matar; Philippe Poitras; Kevin Smit; Olivier May
Journal:  Clin Orthop Relat Res       Date:  2008-10-16       Impact factor: 4.176

6.  Component alignment in hip resurfacing using computer navigation.

Authors:  Chris Bailey; Rehan Gul; Mark Falworth; Steven Zadow; Roger Oakeshott
Journal:  Clin Orthop Relat Res       Date:  2008-10-30       Impact factor: 4.176

7.  The First SICOT Oral Presentation Award 2011: imageless computer-assisted femoral component positioning in hip resurfacing: a prospective randomised trial.

Authors:  Maik Stiehler; Jens Goronzy; Albrecht Hartmann; Frank Krummenauer; Klaus-Peter Günther
Journal:  Int Orthop       Date:  2013-02-06       Impact factor: 3.075

8.  Hip resurfacing data from national joint registries: what do they tell us? What do they not tell us?

Authors:  Kristoff Corten; Steven J MacDonald
Journal:  Clin Orthop Relat Res       Date:  2010-02       Impact factor: 4.176

Review 9.  [Metal-on-metal hybrid hip resurfacing. Development and current state].

Authors:  M Hoberg; M J Le Duff; H C Amstutz
Journal:  Orthopade       Date:  2008-07       Impact factor: 1.087

10.  [Surgical principles and clinical experiences with the DUROM hip resurfacing system using a lateral approach].

Authors:  Sascha Gravius; Torsten Mumme; Oliver Weber; Philipp Berdel; Dieter Christian Wirtz
Journal:  Oper Orthop Traumatol       Date:  2009-12       Impact factor: 1.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.